আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - sitagliptinum hýdróklóríð; metforminum hýdróklóríð - filmuhúðuð tafla - 50mg/850 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg/1000 mg

আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg/850 mg

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - sykursýki, tegund 2 - lyf notuð við sykursýki - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , þrefaldur samsetning meðferð) sem viðbót til að fæði og æfing í sjúklingar ekki nægilega stjórn á eigin hámarks þolað skammt af sjúklingar og sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

gedeon richter plc. - follitrópín alfa - anovulation - hormón kynlíf og stillum kynfæri - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. Í klínískum raunir þessar sjúklinga sem voru skilgreind af innræn blóðvatn ace stigi < 1. 2 ae / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - augnlækningar - eylea er ætlað fyrir fullorðna fyrir meðferð:neovascular (blautur) aldri-tengjast ský á auga (rÍsa);sjón skert vegna ský bjúg efri að sjónhimnu æð stíflu (útibú rvo eða central rvo);sjón skert vegna sykursýki ský bjúg (dme);sjón skert vegna myopic æðu neovascularisation (myopic cnv).

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

novo nordisk a/s - insúlín aspart - sykursýki - drugs used in diabetes, insulins and analogues for injection, fast-acting - meðferð sykursýki hjá fullorðnum, unglingum og börnum á aldrinum 1 ára og eldri.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.